Insider Activity Spotlight: Enact Holdings’ Latest Sale by General Counsel
A Quiet Sell in a Bull Market On August 17, 2026, General Counsel and Secretary Evan Stolove announced the sale of 20,024 restricted shares of Enact Holdings at an average price of $49.52—just below the $50.04 closing price. The transaction, filed under Rule 144, represents a modest 0.4 % of Stolove’s post‑transaction holdings (32,003 shares). In the context of Enact’s 2026 trading range (52‑week high $50.56, low $34.64) and a year‑to‑date gain of nearly 32 %, the sale appears more routine than disruptive. Investors note that the share price was virtually unchanged and the market buzz was modest (11 % communication intensity, neutral sentiment).
What This Means for Enact Investors Stolove’s decision to liquidate a small slice of his restricted holdings could signal confidence in the company’s near‑term outlook. The sale came at a time when Enact’s share price was consolidating after a sharp rally, suggesting that insiders are comfortable taking modest profits before the next earnings cycle. Moreover, the fact that no other insiders have sold in the past 90 days—an unusual pattern for a company experiencing such a rally—may reassure shareholders that the leadership team is not panicking. Analysts should monitor whether this sell-off is part of a larger trend of insider divestitures that could precede a volatility spike.
Evan Stolove’s Transaction Profile Stolove’s trading history shows a consistent pattern of buying restricted stock units (RSUs) in early 2026, followed by periodic sales of common stock at or near market price. Over the last six months, he has bought approximately 1,300 RSUs and sold roughly 80,000 shares of common stock, netting a modest loss on the RSU side but realizing gains when selling common shares. His transactions are typically executed through Fidelity Brokerage Services under Rule 144, indicating a preference for liquidity and compliance. The most recent sale is the first of three consecutive months without insider sales, underscoring a temporary lull in his trading activity.
Investor Takeaway For investors, Stolove’s sale is a small, technically neutral event in an otherwise bullish environment. It reflects a cautious profit‑taking approach rather than a signal of distress. The broader insider activity—especially the high volume of sales from Genworth’s holding company in June—suggests that market participants are actively managing exposure. If the trend of insider selling continues, it may prompt a reevaluation of Enact’s valuation and risk profile. However, the company’s strong fundamentals—high market cap, solid P/E ratio of 10.48, and stable mortgage‑insurance business—provide a cushion against short‑term volatility. Keeping an eye on future insider filings will help determine whether this sell‑off is an isolated move or the first in a larger liquidity cycle.
| Date | Owner | Transaction Type | Shares | Price per Share | Security |
|---|---|---|---|---|---|
| 2026-08-17 | Stolove Evan (EVP, Gen. Counsel & Secretary) | Sell | 20,024.00 | 49.52 | Common Stock |
